SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Pacira BioSciences, Inc. – ‘10-K’ for 12/31/12 – ‘EX-21.1’

On:  Thursday, 3/7/13, at 2:56pm ET   ·   For:  12/31/12   ·   Accession #:  1047469-13-2336   ·   File #:  1-35060

Previous ‘10-K’:  ‘10-K’ on 3/27/12 for 12/31/11   ·   Next:  ‘10-K’ on 2/25/14 for 12/31/13   ·   Latest:  ‘10-K’ on 2/29/24 for 12/31/23   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/07/13  Pacira BioSciences, Inc.          10-K       12/31/12   87:9M                                     Toppan Merrill-FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    979K 
 2: EX-10.47    Material Contract                                   HTML    318K 
 3: EX-10.48    Material Contract                                   HTML    163K 
 4: EX-21.1     Subsidiaries List                                   HTML     20K 
 5: EX-23.1     Consent of Experts or Counsel                       HTML     25K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     28K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     28K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     24K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     24K 
59: R1          Document and Entity Information                     HTML     51K 
45: R2          Consolidated Balance Sheets                         HTML    144K 
57: R3          Consolidated Balance Sheets (Parenthetical)         HTML     49K 
61: R4          Consolidated Statements of Operations               HTML     90K 
80: R5          Consolidated Statements of Comprehensive Loss       HTML     48K 
48: R6          Consolidated Statements of Stockholders' Equity     HTML    135K 
                (Deficit)                                                        
56: R7          Consolidated Statements of Cash Flows               HTML    180K 
41: R8          Business                                            HTML     33K 
31: R9          Summary of Significant Accounting Policies          HTML     67K 
81: R10         Recent Accounting Pronouncements                    HTML     26K 
63: R11         Financial Instruments                               HTML     54K 
62: R12         Inventories                                         HTML     32K 
68: R13         Fixed Assets                                        HTML     38K 
69: R14         Goodwill and Intangible Assets                      HTML     55K 
66: R15         Accrued Expenses                                    HTML     31K 
70: R16         Debt                                                HTML     51K 
58: R17         Stockholders' Equity                                HTML     48K 
60: R18         Stock Plans                                         HTML     73K 
65: R19         Earnings Per Share                                  HTML     43K 
87: R20         Cost of Revenues                                    HTML     31K 
76: R21         Income Taxes                                        HTML     59K 
52: R22         Other Employee Benefits                             HTML     25K 
64: R23         Commercial Partners and Other Agreements            HTML     35K 
54: R24         Related Party Transactions                          HTML     35K 
23: R25         Commitments and Contingencies                       HTML     42K 
77: R26         Subsequent Events                                   HTML     26K 
84: R27         Summary of Significant Accounting Policies          HTML    145K 
                (Policies)                                                       
36: R28         Summary of Significant Accounting Policies          HTML     40K 
                (Tables)                                                         
35: R29         Financial Instruments (Tables)                      HTML     53K 
39: R30         Inventories (Tables)                                HTML     29K 
40: R31         Fixed Assets (Tables)                               HTML     33K 
42: R32         Goodwill and Intangible Assets (Tables)             HTML     52K 
21: R33         Accrued Expenses (Tables)                           HTML     30K 
74: R34         Debt (Tables)                                       HTML     35K 
50: R35         Stockholders' Equity (Tables)                       HTML     37K 
53: R36         Stock Plans (Tables)                                HTML     77K 
26: R37         Earnings Per Share (Tables)                         HTML     43K 
86: R38         Cost of Revenues (Tables)                           HTML     30K 
16: R39         Income Taxes (Tables)                               HTML     54K 
43: R40         Commitments and Contingencies (Tables)              HTML     29K 
79: R41         Summary of Significant Accounting Policies          HTML     29K 
                (Details)                                                        
25: R42         Summary of Significant Accounting Policies          HTML     43K 
                (Details 2)                                                      
34: R43         Summary of Significant Accounting Policies          HTML     31K 
                (Details 3)                                                      
38: R44         Financial Instruments (Details)                     HTML     26K 
46: R45         Financial Instruments (Details 2)                   HTML     47K 
20: R46         Financial Instruments (Details 3)                   HTML     31K 
30: R47         Inventories (Details)                               HTML     42K 
18: R48         Fixed Assets (Details)                              HTML     52K 
78: R49         Goodwill and Intangible Assets (Details)            HTML     44K 
24: R50         Goodwill and Intangible Assets (Details 2)          HTML     59K 
75: R51         Accrued Expenses (Details)                          HTML     36K 
27: R52         Debt (Details)                                      HTML    169K 
44: R53         Stockholders' Equity (Details)                      HTML     61K 
17: R54         Stockholders' Equity (Details 2)                    HTML     53K 
19: R55         Stock Plans (Details)                               HTML     37K 
37: R56         Stock Plans (Details 2)                             HTML     30K 
22: R57         Stock Plans (Details 3)                             HTML    117K 
82: R58         Earnings Per Share (Details)                        HTML     42K 
49: R59         Earnings Per Share (Details 2)                      HTML     33K 
67: R60         Cost of Revenues (Details)                          HTML     30K 
29: R61         Income Taxes (Details)                              HTML     79K 
32: R62         Income Taxes (Details 2)                            HTML     45K 
73: R63         Other Employee Benefits (Details)                   HTML     25K 
71: R64         Commercial Partners and Other Agreements (Details)  HTML     29K 
51: R65         Related Party Transactions (Details)                HTML     60K 
72: R66         Commitments and Contingencies (Details)             HTML     63K 
28: R67         Commitments and Contingencies (Details 2)           HTML     33K 
55: R68         Commitments and Contingencies (Details 3)           HTML     32K 
83: R69         Subsequent Events (Details)                         HTML     42K 
85: XML         IDEA XML File -- Filing Summary                      XML    125K 
33: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    909K 
10: EX-101.INS  XBRL Instance -- pcrx-20121231                       XML   1.48M 
12: EX-101.CAL  XBRL Calculations -- pcrx-20121231_cal               XML    258K 
15: EX-101.DEF  XBRL Definitions -- pcrx-20121231_def                XML    769K 
13: EX-101.LAB  XBRL Labels -- pcrx-20121231_lab                     XML   3.14M 
14: EX-101.PRE  XBRL Presentations -- pcrx-20121231_pre              XML   1.39M 
11: EX-101.SCH  XBRL Schema -- pcrx-20121231                         XSD    250K 
47: ZIP         XBRL Zipped Folder -- 0001047469-13-002336-xbrl      Zip    232K 


‘EX-21.1’   —   Subsidiaries List


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]




EXHIBIT 21.1

 

SUBSIDIARIES OF THE REGISTRANT

 

Pacira Pharmaceuticals, Inc., a California corporation

 

Pacira Ltd., company organized under the laws of the United Kingdom

 




2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/13/13  SEC                               UPLOAD9/20/17    1:34K  Pacira BioSciences, Inc.
12/02/13  SEC                               UPLOAD9/20/17    1:153K Pacira BioSciences, Inc.
Top
Filing Submission 0001047469-13-002336   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 26, 2:03:02.1pm ET